TWO YEAR OUTCOMES OF LOW-DOSE VS VERY LOW-DOSE EXTENDED-RELEASE TACROLIMUS / MYCOPHENOLATE MOFETIL IN DE NOVO KIDNEY TRANSPLANTATION: A MULTI-CENTER RANDOMIZED CONTROLLED TRIAL